Tenaya Therapeutics, Inc. (TNYA)
0.688
-0.01
(-1.05%)
USD |
NASDAQ |
Sep 04, 11:32
Tenaya Therapeutics Research and Development Expense (Annual) : 68.61M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 68.61M |
| December 31, 2024 | 86.74M |
| December 31, 2023 | 98.04M |
| December 31, 2022 | 94.54M |
| Date | Value |
|---|---|
| December 31, 2021 | 54.39M |
| December 31, 2020 | 31.10M |
| December 31, 2019 | 23.15M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Intellia Therapeutics, Inc. | 379.09M |
| Arrowhead Pharmaceuticals, Inc. | 585.26M |
| Oncolytics Biotech, Inc. | 13.31M |
| Sangamo Therapeutics, Inc. | 112.67M |
| Sarepta Therapeutics, Inc. | 1.493B |